Pathological and clinical impact of neoadjuvant chemoradiotherapy using full-dose gemcitabine and concurrent radiation for resectable pancreatic cancer

Adjuvant gemcitabine versus NEOadjuvant gemcitabine/oxaliplatin plus adjuvant gemcitabine in resectable pancreatic cancer: a randomized multicenter phase III study (NEOPAC study)

(2011) Stefan Heinrich et al.   BMC CANCER

Long-term Outcomes of Neoadjuvant Chemotherapy (NC) before Chemoradiation (CRT) for Locally Advanced Pancreatic Cancer (LAPC)

(2011) N.D. Arvold et al.   INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS

Neo-adjuvant Chemoradiation Therapy Using S-1 Followed by Surgical Resection in Patients with Pancreatic Cancer

(2011) Sohei Satoi et al.   JOURNAL OF GASTROINTESTINAL SURGERY

Neoadjuvant GTX Chemotherapy and IMRT-based chemoradiation for borderline resectable pancreatic cancer

(2011) Manish Patel et al.   JOURNAL OF SURGICAL ONCOLOGY

Preoperative chemoradiation reduces the risk of pancreatic fistula after distal pancreatectomy for pancreatic adenocarcinoma

(2011) Hidenori Takahashi et al.   SURGERY

NeoGemTax: Gemcitabine and Docetaxel as Neoadjuvant Treatment for Locally Advanced Nonmetastasized Pancreatic Cancer

(2011) Klaus Sahora et al.   WORLD JOURNAL OF SURGERY

Management of delayed major visceral arterial bleeding after pancreatic surgery

(2011) Markus Schäfer et al.   HPB

Serum CA19–9 Alterations During Preoperative Gemcitabine-Based Chemoradiation Therapy for Resectable Invasive Ductal Carcinoma of the Pancreas as an Indicator for Therapeutic Selection and Survival

(2010) Hidenori Takahashi et al.   ANNALS OF SURGERY

Nutritional predictors of postoperative outcome in pancreatic cancer

(2010) M. Kanda et al.   BRITISH JOURNAL OF SURGERY

Pseudoaneurysm of the lingual artery after concurrent intra-arterial chemotherapy with radiotherapy for advanced tongue cancer

(2010) Shigeyuki Murono et al.   HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK

Novel postoperative adjuvant strategy prevents early hepatic recurrence after resection of pancreatic cancer

(2010) Masayuki Sho et al.   Journal of Hepato-Biliary-Pancreatic Sciences

Randomized phase II study of gemcitabine plus radiotherapy versus gemcitabine, 5-fluorouracil, and cisplatin followed by radiotherapy and 5-fluorouracil for patients with locally advanced, potentially resectable pancreatic adenocarcinoma

(2010) Jerome Landry et al.   JOURNAL OF SURGICAL ONCOLOGY

Number of Metastatic Lymph Nodes, but Not Lymph Node Ratio, Is an Independent Prognostic Factor after Resection of Pancreatic Carcinoma

(2010) Yoshiaki Murakami et al.   JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS

A neoadjuvant strategy for pancreatic adenocarcinoma increases the likelihood of receiving all components of care: lessons from a single-institution database

(2010) May Piperdi et al.   HPB

Neoadjuvant therapy may lead to successful surgical resection and improved survival in patients with borderline resectable pancreatic cancer

(2010) Rebecca J. McClaine et al.   HPB

Preoperative/Neoadjuvant Therapy in Pancreatic Cancer: A Systematic Review and Meta-analysis of Response and Resection Percentages

(2010) Sonja Gillen et al.   PLOS MEDICINE

Long-Term Survival After Pancreatoduodenectomy for Pancreatic Adenocarcinoma

(2009) Thomas Schnelldorfer et al.   ANNALS OF SURGERY

Feasibility and Efficacy of Combination Therapy With Preoperative Full-Dose Gemcitabine, Concurrent Three-Dimensional Conformal Radiation, Surgery, and Postoperative Liver Perfusion Chemotherapy for T3-Pancreatic Cancer

(2009) Hiroaki Ohigashi et al.   ANNALS OF SURGERY

A randomised phase III trial comparing gemcitabine with surgery-only in patients with resected pancreatic cancer: Japanese Study Group of Adjuvant Therapy for Pancreatic Cancer

(2009) H Ueno et al.   BRITISH JOURNAL OF CANCER

Prognostic Factors for Survival After Extended Pancreatectomy for Pancreatic Head Cancer

(2009) Koichi Kato et al.   PANCREAS

Surgical Results After Preoperative Chemoradiation Therapy for Patients With Pancreatic Cancer

(2009) Sohei Satoi et al.   PANCREAS

Neoadjuvant Chemotherapy Generates a Significant Tumor Response in Resectable Pancreatic Cancer Without Increasing Morbidity

(2008) Stefan Heinrich et al.   ANNALS OF SURGERY

Prospective Phase II Trial of Neoadjuvant Chemotherapy With Gemcitabine and Cisplatin for Resectable Adenocarcinoma of the Pancreatic Head

(2008) Stefan Heinrich et al.   JOURNAL OF CLINICAL ONCOLOGY

Preoperative Gemcitabine-Based Chemoradiation for Patients With Resectable Adenocarcinoma of the Pancreatic Head

(2008) Douglas B. Evans et al.   JOURNAL OF CLINICAL ONCOLOGY